SurvivorNet on MSN
ASCO 2026: A major prostate cancer trial shows drug can keep high-risk disease from returning for longer
Data from the PROTEUS trial showed that adding a hormone-blocking pill called apalutamide to standard hormone therapy, both ...
By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results ...
Only men with a dangerous genetic variant and a family history of cancer should be offered screening, say UK advisors.
With a new phase 3 win for Erleada (apalutamide), Johnson & Johnson is proposing a solution to a longstanding prostate cancer treatment gap. For patients with high-risk localized or locally advanced ...
The announcement that King Charles III was admitted to a private hospital Friday to undergo a procedure for an enlarged prostate has sparked interest in what is an extremely common condition among ...
NPR's Ayesha Rascoe talks with urologist Ben Davies about the prevalence of prostate cancer, new treatments, and patients' reluctance to discuss the disease and its aftermath. Early last week, after ...
Benign prostatic hyperplasia (BPH) and prostate cancer are two of the most common conditions that affect the prostate, a gland that’s part of the male reproductive system. Positioned below the bladder ...
Tribune Content Agency on MSN
The medicine cabinet: Ask the Harvard experts: The prostate medicine that helps pass kidney stones in both men and women
Q: I have a kidney stone that got stuck in the ureter. I was discharged from the emergency department with a prescription for ...
The majority of men in the UK will not be offered prostate cancer screening following a final recommendation from a committee ...
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Newsflash for the kings, queens, and anyone with a penis who hasn't figured it out. The real male ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results